Summary
This report provides comprehensive
information on the therapeutic development for Irritable Bowel Syndrome,
complete with comparative analysis at various stages, therapeutics assessment
by drug target, mechanism of action (MoA), route of administration (RoA) and
molecule type, along with latest updates, and featured news and press releases.
It also reviews key players involved in the therapeutic development for
Irritable Bowel Syndrome and special features on late-stage and discontinued
projects.
Browse Full Report with
Toc @ http://www.acutemarketreports.com/report/irritable-bowel-syndrome-pipeline-review-h1-2015
Acute Market Reports features
investigational drugs from across globe covering over 20 therapy areas and
nearly 3,000 indications. The report is built using data and information
sourced from Acute Market Reports proprietary databases, Company/University
websites, SEC filings, investor presentations and featured press releases from
company/university sites and industry-specific third party sources, put
together by Acute Market Reports team. Drug profiles/records featured in the
report undergoes periodic updation following a stringent set of processes that
ensures that all the profiles are updated with the latest set of information.
Additionally, processes including live news & deals tracking, browser based
alert-box and clinical trials registries tracking ensure that the most recent
developments are captured on a real time basis.
The report enhances decision making
capabilities and help to create effective counter strategies to gain
competitive advantage. It strengthens R&D pipelines by identifying new
targets and MOAs to produce first-in-class and best-in-class products.
Note*: Certain sections in the report
may be removed or altered based on the availability and relevance of data for
the indicated disease.
Browse here for all
category Reports @ http://www.acutemarketreports.com/category/pharmaceutical-market
Scope
- The report provides a snapshot of
the global therapeutic landscape of Irritable Bowel Syndrome
- The report reviews key pipeline
products under drug profile section which includes, product description, MoA
and R&D brief, licensing and collaboration details & other
developmental activities
- The report reviews key players
involved in the therapeutics development for Irritable Bowel Syndrome and
enlists all their major and minor projects
- The report summarizes all the
dormant and discontinued pipeline projects
- A review of the Irritable Bowel
Syndrome products under development by companies and universities/research
institutes based on information derived from company and industry-specific
sources
- Pipeline products coverage based on
various stages of development ranging from pre-registration till discovery and
undisclosed stages
- A detailed assessment of
monotherapy and combination therapy pipeline projects
- Coverage of the Irritable Bowel
Syndrome pipeline on the basis of target, MoA, route of administration and
molecule type
- Latest news and deals relating
related to pipeline products
Reasons to buy
- Provides strategically significant
competitor information, analysis, and insights to formulate effective R&D
development strategies
- Identify emerging players with
potentially strong product portfolio and create effective counter-strategies to
gain competitive advantage
- Develop strategic initiatives by
understanding the focus areas of leading companies
- Identify and understand important
and diverse types of therapeutics under development for Irritable Bowel
Syndrome
- Plan mergers and acquisitions
effectively by identifying key players of the most promising pipeline
- Devise corrective measures for
pipeline projects by understanding Irritable Bowel Syndrome pipeline depth and
focus of Indication therapeutics
- Develop and design in-licensing and
out-licensing strategies by identifying prospective partners with the most
attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by
identifying discontinued projects and understanding the factors that drove them
from pipeline
About Us
Acute Market
Reports is the most sufficient collection of market intelligence services
online. It is your only source that can fulfill all your market research
requirements. We provide online reports from over 100 best publishers and
upgrade our collection regularly to offer you direct online access to the
world’s most comprehensive and recent database with expert perceptions on
worldwide industries, products, establishments and trends. Our database
consists of 200,000+ market research reports with detailed & minute market
research.
CONTACT US
Chris Paul
ACUTE MARKET REPORTS
Office No 101, 1st Floor ,
Aditi Mall, Baner,
Pune, MH, 411045
India
Toll Free(US/CANADA): +1-855-455-8662
India: +91 7755981103
Email: sales@acutemarketreports.com
Office No 101, 1st Floor ,
Aditi Mall, Baner,
Pune, MH, 411045
India
Toll Free(US/CANADA): +1-855-455-8662
India: +91 7755981103
Email: sales@acutemarketreports.com
No comments:
Post a Comment